Orion Pharma (DHA:ORIONPHARM) EPS (Basic) : BDT-0.47 (TTM As of Mar. 2025)

View and export this data going back to 2013. Start your Free Trial

What is Orion Pharma EPS (Basic)?

Orion Pharma's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was BDT0.02. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was BDT-0.47.

Orion Pharma's EPS (Diluted) for the three months ended in Mar. 2025 was BDT0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was BDT-0.47.

Orion Pharma's EPS without NRI for the three months ended in Mar. 2025 was BDT0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was -0.46.

During the past 12 months, Orion Pharma's average EPS without NRIGrowth Rate was -123.60% per year. During the past 3 years, the average EPS without NRI Growth Rate was -30.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was -14.00% per year. During the past 10 years, the average EPS without NRI Growth Rate was -7.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 11 years, Orion Pharma's highest 3-Year average EPS without NRI Growth Rate was 5.40% per year. The lowest was -30.10% per year. And the median was -3.00% per year.

Orion Pharma EPS (Basic) Historical Data

The historical data trend for Orion Pharma's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Pharma EPS (Basic) Chart

Orion Pharma Annual Data

Trend

Dec13

Dec14

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

EPS (Basic)

Get a 7-Day Free Trial

2.84

4.01

3.62

2.74

1.36

Orion Pharma Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EPS (Basic)	Get a 7-Day Free Trial															0.42	-0.29	0.24	-0.44	0.02

Orion Pharma EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Orion Pharma's Basic EPS for the fiscal year that ended in Jun. 2024 is calculated as

Basic EPS (A: Jun. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(318.117	-	0)	/	234.000
	=	1.36

Orion Pharma's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(5.824	-	0)	/	234.000
	=	0.02

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT-0.47

Orion Pharma (DHA:ORIONPHARM) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Orion Pharma EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Orion Pharma's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Orion Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Utilities » Utilities - Independent Power Producers » Orion Pharma Ltd (DHA:ORIONPHARM) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

153-154 Tejgaon Industrial Area, Orion House, Dhaka, BGD, 1208

Website

https://www.orionpharmabd.com

Orion Pharma Ltd is a pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical drugs and medicines. It provides its drugs in various dosage forms including tablet, capsule, syrup, suspension, injection, dry powder for syrup and suspension, for therapeutic groups like anticancer, antibiotics, antidiabetics, anxiolytics, diuretics, cardiovascular drugs, and others. In addition, the company is also involved in power generation activities. It generates maximum revenue from power generation activities. The group principally carries out its business operations and markets its products in Bangladesh.

Orion Pharma Headlines

No Headlines